Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Looks To Xinlay Back-Up Study After Negative Advisory Cmte. Review

Sep 19 2005

• By The Pink Sheet

Related Content

Iressa Data Likely To Be Revisited By FDA Oncologic Cmte. In June Or July

Apr 18 2005

Abbott Xinlay Review By Oncologic Committee Expected In Mid-September

May 23 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window